Compare Stocks → A lot of people are making this costly mistake (From WealthPress) (Ad) Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS). Comparison Ideas Agriculture StocksAirline StocksApparel StocksArtificial Intelligence StocksAutomotive StocksBank StocksBitcoin StocksBlockchain StocksCanadian StocksCannabis StocksCasino StocksChatGPT StocksChinese StocksCloud Storage StocksCoronavirus Therapeutics StocksCryptocurrency StocksCybersecurity StocksDefense StocksDividend StocksDow 30 StocksEcommerce StocksElectric Vehicles StocksEnergy StocksEntertainment StockseSports StocksEV Charging StocksFertilizer StocksGold StocksGrocery StocksGrowth StocksHealthcare StocksHigh Dividend StocksHome Office StocksHotel StocksLarge Cap StocksLeisure StocksLithium StocksMagnificent Seven StocksMATANA StocksMega Cap StocksMeme StocksMetaverse StocksMid Cap StocksMining StocksMusic Industry StocksNanotechnology StocksNFT StocksOil StocksOutdoor Activities StocksPharmaceutical StocksRenewable Energy StocksRestaurant StocksRetail StocksSemiconductor StocksSocial Media StocksSolar StocksSpace StocksStay-At-Home StocksTechnology StocksTelecom StocksToy StocksUtility StocksVaccine StocksVideo Game StocksVirtual Reality StocksWallStreetBets Stocks Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare Share Comparison Share Comparison NASDAQ:ICGNYSEARCA:IQSUNASDAQ:ISDXNASDAQ:PPHNASDAQ:USAT Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Stocks - Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeICGIntchains Group$8.60+2.4%$9.52$5.81▼$14.22$514.45MN/A3,883 shs1,293 shsIQSUIQ Candriam ESG U.S. Large Cap Equity ETF$44.36+0.0%$43.21$34.50▼$44.50$443.60M1.0514,758 shs617 shsISDXInvesco RAFI Strategic Developed ex-US ETF$26.54$27.18$22.82▼$30.61$399.43M0.93248,859 shs147,443 shsPPHVanEck Pharmaceutical ETF$90.70-0.2%$88.31$74.05▼$91.16$470.73M0.72131,794 shs89,722 shsUSATCantaloupe$6.46+2.5%$6.86$4.80▼$12.94$459.17M2.25291,261 shs208,045 shs10 Best Stocks to Own in 2024Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2024 and why they should be in your portfolio. Get This Free ReportPrice PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceICGIntchains Group+3.61%0.00%-16.10%-30.48%+2.99%IQSUIQ Candriam ESG U.S. Large Cap Equity ETF+0.05%+0.11%+2.12%+5.64%+28.58%ISDXInvesco RAFI Strategic Developed ex-US ETF0.00%0.00%0.00%0.00%+0.26%PPHVanEck Pharmaceutical ETF-0.21%+1.35%+0.64%+11.47%+18.21%USATCantaloupe0.00%+2.70%-0.46%-13.52%+14.13%Did You Get Your Free Bitcoin Yet? (Ad)And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.>> Register right hereMarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationICGIntchains GroupN/AN/AN/AN/AN/AN/AN/AN/AIQSUIQ Candriam ESG U.S. Large Cap Equity ETFN/AN/AN/AN/AN/AN/AN/AN/AISDXInvesco RAFI Strategic Developed ex-US ETFN/AN/AN/AN/AN/AN/AN/AN/APPHVanEck Pharmaceutical ETFN/AN/AN/AN/AN/AN/AN/AN/AUSATCantaloupeN/AN/AN/AN/AN/AN/AN/AN/AAnalyst RatingsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceICGIntchains GroupN/AN/AN/AN/AIQSUIQ Candriam ESG U.S. Large Cap Equity ETF0.00N/A$47.206.40% UpsideISDXInvesco RAFI Strategic Developed ex-US ETF0.00N/AN/AN/APPHVanEck Pharmaceutical ETF0.00N/A$100.5710.88% UpsideUSATCantaloupeN/AN/AN/AN/ACurrent Analyst RatingsSales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookICGIntchains Group$11.58M44.43N/AN/A$2.24 per share3.84IQSUIQ Candriam ESG U.S. Large Cap Equity ETFN/AN/AN/AN/AN/AN/AISDXInvesco RAFI Strategic Developed ex-US ETFN/AN/AN/AN/AN/AN/APPHVanEck Pharmaceutical ETFN/AN/AN/AN/AN/AN/AUSATCantaloupe$150.91M3.04N/AN/AN/A∞Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateICGIntchains Group-$3.78M-$0.04N/A∞N/A-31.11%-2.70%-2.65%5/22/2024 (Estimated)IQSUIQ Candriam ESG U.S. Large Cap Equity ETFN/AN/A20.80∞N/AN/AN/AN/AN/AISDXInvesco RAFI Strategic Developed ex-US ETFN/AN/A14.84∞N/AN/AN/AN/AN/APPHVanEck Pharmaceutical ETFN/AN/A16.59∞N/AN/AN/AN/AN/AUSATCantaloupeN/A-$0.48N/A∞N/AN/AN/AN/AN/ALatest USAT, IQSU, PPH, ICG, and ISDX EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails2/28/2024Q4 2023ICGIntchains GroupN/A$0.02+$0.02$0.02N/A$4.99 millionDividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthICGIntchains GroupN/AN/AN/AN/AN/AIQSUIQ Candriam ESG U.S. Large Cap Equity ETF$0.471.06%N/AN/AN/AISDXInvesco RAFI Strategic Developed ex-US ETF$1.816.82%N/AN/A1 YearsPPHVanEck Pharmaceutical ETF$1.701.87%N/AN/AN/AUSATCantaloupeN/AN/AN/AN/AN/ADebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioICGIntchains GroupN/A28.3226.83IQSUIQ Candriam ESG U.S. Large Cap Equity ETFN/AN/AN/AISDXInvesco RAFI Strategic Developed ex-US ETFN/AN/AN/APPHVanEck Pharmaceutical ETFN/AN/AN/AUSATCantaloupeN/AN/AN/AOwnershipInstitutional OwnershipCompanyInstitutional OwnershipICGIntchains GroupN/AIQSUIQ Candriam ESG U.S. Large Cap Equity ETFN/AISDXInvesco RAFI Strategic Developed ex-US ETFN/APPHVanEck Pharmaceutical ETFN/AUSATCantaloupe61.59%Insider OwnershipCompanyInsider OwnershipICGIntchains GroupN/AIQSUIQ Candriam ESG U.S. Large Cap Equity ETFN/AISDXInvesco RAFI Strategic Developed ex-US ETFN/APPHVanEck Pharmaceutical ETFN/AUSATCantaloupe18.80%MiscellaneousCompanyEmployeesShares OutstandingFree FloatOptionableICGIntchains Group10159.82 millionN/ANot OptionableIQSUIQ Candriam ESG U.S. Large Cap Equity ETF147,00010.00 millionN/ANot OptionableISDXInvesco RAFI Strategic Developed ex-US ETF147,00015.05 millionN/ANot OptionablePPHVanEck Pharmaceutical ETF147,0005.19 millionN/AOptionableUSATCantaloupeN/A71.08 millionN/ANot OptionableUSAT, IQSU, PPH, ICG, and ISDX HeadlinesSourceHeadlineStockNews.com Initiates Coverage on Cantaloupe (NASDAQ:USAT)americanbankingnews.com - March 23 at 2:14 AMBenchmark Initiates Coverage of Cantaloupe (CTLP) with Buy Recommendationmsn.com - February 23 at 8:36 PMCantaloupe Stock (NASDAQ:CTLP), Analyst Ratings, Price Targets, Predictionsbenzinga.com - February 22 at 8:59 AMDr. Melon Negahealth.usnews.com - January 11 at 8:20 AMLatest salmonella outbreak recalls include whole cantaloupes and Walmart fruit dishessacbee.com - November 27 at 7:55 AMDozens sickened in cantaloupe recall; Ohio impactedfox8.com - November 22 at 7:35 PMBerenberg Initiates Coverage of Cantaloupe (CTLP) with Buy Recommendationmsn.com - October 3 at 7:58 PMCantaloupe recalled due to possible salmonella contaminationtoday.com - October 3 at 2:58 PMQ4 2023 Cantaloupe Inc Earnings Callfinance.yahoo.com - September 17 at 7:29 AMWhy Cantaloupe Stock Dropped Todaymsn.com - September 7 at 5:56 PMMelon Mania: Why Crown Melons Are the Most Luxurious Food to Eat Right Nowobserver.com - August 28 at 9:35 AMHealth Benefits of Honeydew Melonhealth.com - August 20 at 9:31 PMCantaloupe green smoothiemensjournal.com - July 22 at 8:42 AMCantaloupe Margaritaspbs.org - June 24 at 10:15 AMCantaloupe fined $1.5M in SEC accounting fraud casecomplianceweek.com - June 6 at 12:58 PMOhio festival guide 2023: from walleye to frogs, strawberries and meloncleveland.com - June 2 at 1:09 AMMultistate Outbreaks of Salmonella Serotype Poona Infections Associated With Eating Cantaloupe from Mexico - United States and Canada, 2000-2002medscape.com - May 2 at 10:02 AMQuite a few insiders invested in Cantaloupe, Inc. (NASDAQ:CTLP) last year which is positive news for shareholdersfinance.yahoo.com - April 26 at 7:38 PMWater Melon mandi pricescommodityonline.com - April 4 at 1:55 PMRoss Chastain helps remove wall at Martinsville Speedway to commemorate ‘Hail Melon’nascar.com - March 12 at 6:54 AMCantaloupe, Inc. (CTLP)uk.finance.yahoo.com - February 16 at 3:15 PMWhy Cantaloupe Stock Exploded 11% Higher Todaymsn.com - February 8 at 3:18 PM10 Surprising Benefits of Honeydew Melonhealthline.com - January 25 at 3:18 PMWhat’s the Difference Between Honeydew Melon and Cantaloupe?healthline.com - January 23 at 10:43 AMNew MarketBeat Followers Over TimeMedia Sentiment Over TimeCompany DescriptionsIntchains GroupNASDAQ:ICGIntchains Group Limited designs and sells application-specific integrated circuit chips and ancillary software and hardware for blockchain applications in the People's Republic of China. It serves distributors, companies, and individuals. Intchains Group Limited was founded in 2017 and is based in Pudong, China.IQ Candriam ESG U.S. Large Cap Equity ETFNYSEARCA:IQSUThe IQ Candriam ESG US Equity ETF (IQSU) is an exchange-traded fund that is based on the IQ Candriam ESG US Equity index. The fund tracks a proprietary index of large-cap US stocks selected by ESG criteria and weighted by market capitalization. IQSU was launched on Dec 17, 2019 and is managed by IndexIQ.Invesco RAFI Strategic Developed ex-US ETFNASDAQ:ISDXThe Invesco RAFI Strategic Developed ex-US ETF (ISDX) is an exchange-traded fund that is based on the Invesco Strategic Developed ex-US index. The fund tracks an index of large firms in developed markets, ex-US. Stocks are selected by fundamental and quality metrics and weighted by firm size. ISDX was launched on Sep 12, 2018 and is managed by Invesco.VanEck Pharmaceutical ETFNASDAQ:PPHThe VanEck Pharmaceutical ETF (PPH) is an exchange-traded fund that is based on the MVIS US Listed Pharmaceutical 25 index, a market-cap-weighted index of 25 of the largest global pharmaceutical firms. PPH was launched on Feb 1, 2000 and is managed by VanEck.CantaloupeNASDAQ:USATCantaloupe, Inc. is a software and payments company, which engages in the provision of end-to-end technology solutions for the unattended retail market. It offers Internet of Things (IoT) and machine-to-machine (M2M) services, which include the ability to remotely monitor, control, and report on the results of distributed assets containing the electronic payment solutions. The company was founded by George Raymond Jensen Jr. in January 1992 and is headquartered in Malvern, PA. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.